Abstract-This study aimed to explore the signaling pathways involved in the positive inotropic effect (PIE) of low doses of endothelin-1 (ET-1). Cat papillary muscles were used for force and intracellular Na ϩ concentration (Na ϩ i ) measurements, and isolated cat ventricular myocytes for patch-clamp experiments. ET-1 (5 nmol/L) induced a PIE and an associated increase in Na ϩ i that were abolished by Na ϩ /H ϩ exchanger (NHE) inhibition with HOE642. Reverse-mode Na ϩ /Ca 2ϩ exchanger (NCX) blockade with KB-R7943 reversed the ET-1-induced PIE. These results suggest that the ET-1-induced PIE is totally attributable to the NHE-mediated Na ϩ i increase. However, an additional direct stimulating effect of ET-1 on NCX after the necessary increase in Na ϩ i could occur. Thus, the ET-1-induced increase in Na ϩ i and contractility was compared with that induced by partial inhibition of the Na ϩ /K ϩ ATPase by lowering extracellular K
ϩ i increase. However, an additional direct stimulating effect of ET-1 on NCX after the necessary increase in Na ϩ i could occur. Thus, the ET-1-induced increase in Na In the presence of HOE642 and after increasing contractility and Na ϩ i by low K ϩ o , ET-1 induced an additional PIE that was reversed by KB-R7943 or the protein kinase C (PKC) inhibitor chelerythrine. ET-1 increased the NCX current and negatively shifted the NCX reversal potential (E NCX ). HOE642 attenuated the increase in NCX outward current and abolished the E NCX shift. These results indicate that whereas the NHE-mediated ET-1-induced increase in Na ϩ i seems to be mandatory to drive NCX in reverse and enhance contractility, Na ϩ i -independent and PKC-dependent NCX stimulation appears to additionally contribute to the PIE. However, it is important to stress that the latter can only occur after the primary participation of the former. Key Words: contraction Ⅲ ion channels Ⅲ endothelin E ndothelin-1 (ET-1) is a powerful inotropic agent that induces this effect acting through different intracellular signaling pathways. [1] [2] [3] [4] However, at doses that increase contractility by Ϸ20%, the positive inotropic effect (PIE) is entirely attributable to activation of the reverse mode of the Na ϩ /Ca 2ϩ exchanger (NCX). 5 This increase in contractility is similar in magnitude to that detected during the slow force response of myocardial stretch. 6 -8 A sustained increase in intracellular Ca 2ϩ through the NCX reverse mode induced by an increase in intracellular Na ϩ (Na ϩ i ) produced by the activation of the Na ϩ /H ϩ exchanger (NHE) may represent the signaling link between this transporter and cardiac hypertrophy. 9 -11 In fact, we demonstrated recently that this mechanism is responsible for the increase in contractility induced by ET-1. 5 We proposed that ET-1 activates the NHE, which increases Na ϩ i and shifts the NCX reversal potential (E NCX ) to a more negative voltage. These changes give more time for NCX to operate in reverse mode during the action potential and promote Ca 2ϩ influx to the cell, determining the increase in force. 5 It is well known that activation of protein kinase C (PKC) is a downstream pathway of ET-1 receptor binding. 4 Consistently, it has been shown that PKC phosphorylates the NCX protein after ET-1 stimulation. 12 Moreover, a direct PKCdependent increase in the NCX current (I NCX ) induced by ET-1 in guinea pig myocytes was reported previously. 13 Thus, the possibility exists that a direct effect of ET-1 on NCX could also contribute to the PIE of this peptide after NCX is driven to the reverse mode by the mandatory increase in Na ϩ i produced by activation of the NHE. In other words, the increase in Na ϩ i could be a necessary but not exclusive condition to mediate the ET-1-induced Ca 2ϩ influx through the NCX reverse mode. The investigation of this hypothesis constitutes the main purpose of the present study.
The overall results obtained herein allow us to suggest that the cardiac NCX reverse mode is modulated by ET-1 through 2 different pathways: (1) an Na ϩ i -dependent one, consistent with a negative shift of E NCX after a rise in Na ϩ i attributable to the NHE activation; and (2) an Na ϩ i -independent and PKCdependent NCX stimulation. Both pathways appear to con-tribute to the ET-1-induced PIE. However, the latter seems to contribute to this effect only after primary participation of the former, which appears to be a mandatory step.
Materials and Methods
The investigation conforms to the Guide for the Care 
Experimental Protocols
To analyze the above-mentioned hypothesis, 3 different experimental approaches were assayed in the present work. (1) We compared the increase in Na 
Pharmacological Interventions
HOE642 (1 mol/L) was used to inhibit the NHE, KB-R7943 (5 mol/L), to inhibit the NCX reverse mode, and chelerythrine (1 mol/L), to block PKC activation.
Statistics
Data are expressed as meanϮSEM. To detect significant differences, paired or unpaired t test or repeated-measures 1-way ANOVA followed by Student Newman-Keuls as post hoc test were used as appropriate. A PϽ0.05 was considered to indicate significant differences. (2) is accompanied by an increase in Na ϩ i without changes in pH i . The lack of changes in pH i after NHE activation when bicarbonate is present in the medium has been suggested previously. 5, 6, 14 Note that a further increase in Na ϩ i was detected after application of KB-R7943, suggesting that this compound blocked the exchange of Na Although these experiments are suggesting that the PIE of this ET-1 dose is entirely attributable to stimulation of the NCX reverse mode, the possibility exists that the compound used for blocking this NCX operation mode would be acting on other mechanisms. However, as shown in Figure 2 , this was not the case. We were unable to show any effect of KB-R7943 (5 mol/L) on contractility under our control conditions ( Figure  2A ). These results also indicate that the NCX reverse mode does not contribute to basal contractility. KB-R7943 even failed to affect contractility after increasing it by enhancing extracellular Ca 2ϩ concentration in a magnitude enough to increase developed force by Ϸ20% ( Figure 2B ), which is the effect produced by the dose of ET-1 used in the present work.
Results
To test the possibility that in addition to the Na ϩ i -dependent mechanism, there is also a direct stimulatory effect of ET-1 on NCX, pilot experiments in which an increase in Na lish the relationship between the increase in Na ϩ i and developed force in our preparations, no consistent relationship between both parameters was found after 1, 2, or 5 mol/L ouabain (data not shown). These results might be explained by nonspecific effects of this compound 15, 16 or failure to select the right dose. Then we decided to increase Na ϩ i by partial inhibition of the Na Figure 3 , inset), indicating that it was attributable to activation of the NCX reverse mode. However, when the Na ϩ i levels were augmented by ET-1-induced activation of NHE, the increase in force lies above this relationship. Therefore, for a given Na If ET-1 is directly stimulating NCX through a PKC pathway, 12, 13 and this mechanism is inducing additional effects to NHE activation, we should detect a further increase in developed force at higher-than-normal Na ϩ i and under NHE blockade. Figure 4 shows that this was the case. After the low K ϩ o -induced PIE and despite the NHE inhibition, an additional increase in force was now evident when ET-1 was added to the extracellular solution ( Figure 4A ). KB-R7943 reversed both PIEs, that of low K ϩ o and that of ET-1, indicating that they were attributable to activation of the NCX reverse mode. On average, ET-1 induced an increase of developed force of 10.8Ϯ0.4% with respect to the steady-state value obtained with low K ϩ o ( Figure 4B ). To confirm that this ET-1-induced PIE is Na ϩ i independent, we performed additional experiments in which we simultaneously recorded force and Na ϩ i ( Figure 5) . A similar pharmacological protocol of Figure 4 was followed, but in this case, instead of KB-R7943, the PKC inhibitor chelerythrine (1 mol/L) was added after the ET-1-induced PIE reached a steady-state level. Figure 5 clearly shows that under these experimental conditions, ET-1 produces a PIE in the absence of changes in Na ϩ i and that this increase in contractility is completely reversed by PKC inhibition. These overall results indicate that ET-1 is able to induce a PKC-dependent PIE in the presence of NHE inhibition only after the increase in Na ϩ i produced by low K ϩ o , which drives the NCX to the reverse mode. These experiments also indicate that part of the PIE of ET-1 is Na ϩ i independent and thus unrelated to the change in E NCX produced by the increase in Na .69x) . This increase in force may conceivably be assigned to activation of the NCX reverse mode because it was reverted by KB-R7943 (5 mol/L; inset). However, when Na ϩ i levels were augmented by ET-1-induced NHE activation, the results lie above the relationship. In other words, for a similar increase in Na ϩ i , the increase in force was significantly greater in the presence of ET-1, suggesting that this peptide is driving NCX in reverse mode not only through an NHE-mediated increase in Na should detect changes in the I NCX insensitive to NHE blockade. Thus, we next recorded whole-cell currents evoked by depolarizing steps between Ϫ80 and ϩ80 mV in 10-mV increments from a holding potential of Ϫ40 mV. Figure 6A shows the average current-voltage (I-V) relationship for I NCX before and after addition of ET-1 to the bath solution. A statistically significant ET-1-induced enhancement in outward I NCX was observed at potentials higher than Ϫ10 mV with 1 nmol/L ET-1 and at potentials higher than Ϫ40 mV with 10 nmol/L ET-1. A significant increase in inward I NCX was also observed at Ϫ70 and Ϫ80 mV with 10 nmol/L ET-1. A linear fitting of the individual data points of the I-V for each cell was performed to detect the 0 current level of I NCX , representing E NCX , in the absence and presence of ET-1. ET-1 dose-dependently produced a significant E NCX negative shift ( Figure 6B ). To evaluate whether the ET-1-induced E NCX negative shift was attributable to an increase in Na ϩ i secondary to the activation of the NHE, experiments in the presence of HOE642 were performed. Figure 6C shows the effect of HOE642 on the average I-V for I NCX before and after the addition of ET-1 to the bath solution. A statistically significant ET-1-induced enhancement in outward I NCX was observed at potentials Ͼϩ40 mV with 1 nmol/L ET-1 and at potentials higher than Ϫ30 mV with 10 nmol/L ET-1. A significant increase in inward I NCX was also observed at Ϫ70 and Ϫ80 mV with 10 nmol/L ET-1. HOE642 did not affect basal I NCX ( Figure 6A and 6C) . No shift in E NCX was observed in the presence of HOE642 (Figure 6D ), indicating that the ET-1-induced negative shift observed in the absence of this inhibitor was attributable to the increase in Na 
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were evident: the increase in the driving force for the reverse mode induced by the E NCX negative shift and direct stimulation of NCX.
Discussion
We can conclude that a low dose of ET-1, equipotent to the slow force response to myocardial stretch 6 -8 and to doses of angiotensin II that promote the release of ET-1, 5 increases myocardial force by increasing Na ϩ i through the activation of NHE, which in turn stimulates the NCX reverse mode. In the present work, we attempted to answer the following question: Is this increase in Na ϩ i the only mechanism responsible for these mechanical changes? A simplistic approach would be that if prevention of the increase in Na ϩ i by blocking NHE prevented development of the mechanical counterpart, then the increase in Na ϩ i is the determinant of the contractile effect. However, the possibility that the increase in Na ϩ i could be a necessary but not an exclusive mechanism to induce the Ca 2ϩ influx through the NCX in reverse should be considered. In this regard, we are presenting evidence that although blockade of the NCX reverse mode abolished the mechanical counterpart manifested after a rise in Na ϩ i , induced either by ET-1 or by Na ϩ /K ϩ ATPase inhibition, for a given increase in Na ϩ i , the increase in developed force was greater when activation of the NCX reverse mode was induced by ET-1 than when the Na ϩ /K ϩ ATPase was inhibited. Moreover, we also demonstrated that in the presence of NHE inhibition, ET-1 applied after the increase in Na ϩ i produced by low K ϩ o was able to induce an additional PIE that was completely reversed by inhibition of the NCX reverse mode. These results strongly suggest that factors affecting the NCX reverse mode other than the increase in Na ϩ i and the consequent E NCX negative shift are participating when the increase in force is mediated by ET-1. In this regard, our electrophysiological experiments are indicating that ET-1 is also producing a direct stimulation of NCX. A phosphorylation of NCX by a PKCdependent mechanism has been proposed 12, 13 and might represent the subcellular pathway leading to direct stimulation of this transporter. Consistently, we showed in the present work that PKC mediates the Na Figure 1C) . However, it is important to note that the increase in Na ϩ i in the isolated myocytes might reflect changes of this ion in a space in which intracellular dialysis with the solution of the patch pipette cannot maintain the Na ϩ concentration at a constant level. Although it is difficult to imagine how the increase in Na ϩ i can only enhance the NCX reverse mode without slowing the forward mode, we would like to call attention to the fact that the selective inhibitor of the NCX reverse mode blunted the contractile response. However, we cannot completely rule out a contribution of a reduced forward mode of the NCX to the increase in Ca of NHE activation, and (2) an increase in the turnover rate of the NCX units induced by a PKC-dependent pathway. Both pathways appear to contribute to the ET-1-induced PIE. However, the increased turnover rate seems to contribute to this effect only after the change in E NCX produced by NHE activation, which appears to be a necessary step. The fact that basal levels of Na ϩ i are increased in some myocardial diseases such as hypertrophy 17, 18 or heart failure 18, 19 permit the speculation that it would not be mandatory that the aforementioned mechanisms should take place in series. Thus, the relative contribution of these 2 pathways to the ET-1-induced increase in contractility in pathological states is an interesting forthcoming perspective that deserves future attention.
Study Limitations
The main limitations of our study rely on the comparison of the contractile response with an increase in Na ϩ i levels by 2 different interventions, namely ET-1 and low K ϩ o . Although we demonstrated that both interventions increase contractility by NCX in reverse, and that for a given increase in Na ϩ i , ET-1 induced a greater increase in contractility than inhibition of the Na ϩ /K ϩ ATPase, the following possibilities should be analyzed: (1) Despite an equal Na ϩ i in the bulk of the cytosol, the increase of Na ϩ i induced by ET-1 would be higher in a fuzzy space close to NCX. However, a colocalization of NCX and NHE, 20, 21 and also of NCX and the Na ϩ /K ϩ ATPase, 22 have been reported; (2) ET-1 could induce a greater prolongation of the action potential duration (APD) than low K ϩ o , then the influx of Ca 2ϩ through the NCX reverse mode would be greater than that induced by Na ϩ /K ϩ ATPase inhibition. Although the increase in APD by ET-1 has been reported, 23, 24 low K ϩ o can also induce a prolongation of APD, 25 and the differences between both interventions are difficult to evaluate; (3) The way selected by us to increase Na ϩ i (low K ϩ o ), by hyperpolarizing the cell, may promote Ca 2ϩ efflux through the forward mode of NCX, thus reducing PIE. However, no negative inotropic effect was observed after complete block with KB-R7943 of the low K ϩ o -induced PIE ( Figure 3, inset) ; and (4) The increase in Na ϩ i produced by either ET-1 or inhibition of the Na ϩ /K ϩ ATPase may affect regulation of ion channels (ie, Na ϩ -activated K ϩ channels 26 ) and alter membrane potential. However, in our experiments, these potential effects of increased Na 
